MedTrace Logo

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

NCT00244114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-02-18

No results posted yet for this study

Summary

Based on the finding that anaphylactic reactions to Benefix ("FIX") are associated with a specific IgE, a Basophil histamine release assay was selected to evaluate and demonstrate subject sensitization to FIX.

Conditions

  • Hemophilia B

Interventions

DRUG

blood draw

Single blood sample collected to perform histamine release assay.

PROCEDURE

Blood draw

Single blood sample collected to perform histamine release assay.

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2009-12-31
Completion
2009-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00244114 on ClinicalTrials.gov